R
Redhill Biopharma Ltd D
D
RDHL
1.86000
USD
-0.59
(-24.08%)
مغلق
حجم التداول
1,374
الربح لكل سهم
-1
العائد الربحي
-
P/E
-0
حجم السوق
4,269,342
الأخبار المقالات
العنوان: Redhill Biopharma Ltd
القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-relatedproducts in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.